Health
UAE company nears end of Chinese Covid-19 vaccine trial – Devdiscourse
He said G42 has distribution and manufacturing agreements with Sinopharm and hopes to provide the UAE and other regional states with the vaccine, especially tho…
A United Arab Emirates company is nearing the end of Phase III clinical trials of a Chinese COVID-19 vaccine and hopes to manufacture it next year, a representative said. The trial, which began in mid-July, is a partnership between Sinopharm’s China National Biotec Group (CNBG) and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42).
The vaccine uses an inactivated virus; a well-known technology which has been used against diseases such as influenza and measles. T…
-
General17 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News16 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
Noosa News17 hours agoThe Best Things to Do in Brisbane This New Year’s Eve
-
Noosa News21 hours agoMary River cod thriving in Brisbane River catchment, century after relative went extinct